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MOLECULAR AND FUNCTIONAL ANALYSIS OF A CONDITIONAL
KNOCKOUT OF ACTIVIN A
H. Jin, J. Zarebska, J. Saklatvala, T. Vincent. Kennedy Inst. of Rheumatlogy,
Oxford, United Kingdom
Purpose: Osteoarthritis (OA) is the most common degenerative disease
of the joint. Knockout mice have been a very powerful tool to elucidate
the pathogenesis of OA. However, selectively deleting genes in adult
animals in a tissue or time speciﬁc manner, still remains challenging.
Herewe have generated a conditional knockout mouse to study the role
of activin A in a murine model of OA. Activin A is strongly regulated in
human OA and is essential for normal musculoskeletal development
(the constitutive knockout is neonatal lethal).
Methods: Activin A ﬂoxed mice (Actf/f) were crossed with a line
expressing Cre recombinase driven by the human ubiquitin promoter
and controlled by a Tamoxifen-sensitive modiﬁed estrogen receptor
(UbcCreERT2). The resulting mice (UbcCreERT2/Actf/f) were treated
with Tamoxifen (TM) on 3 consecutive days at either 4 weeks (for car-
tilage injury studies), 8 weeks (for OA studies) or 10 weeks (for other
studies) to create pan tissue activin A deletion. Activin Amessenger RNA
production was determined by real time PCR. Activin A protein secre-
tion was measured by enzyme-linked immunosorbent assay (ELISA).
Femurs and tibias were collected at 18 weeks for micro CT imaging.
Results: In activin A conditional knockout (Act-cKO) mice, less than 10%
of activin A mRNA was detected in cartilage, knee joints, spleen, liver
and kidney compared with control levels (Act f/f or UbcCreERT2/Actf/f;
no TM). ELISA showed that activin A secretion upon cartilage injury in
Act-cKO hips was similarly reduced. For functional validation, micro CT
analysis showed that 18 week old female Act-cKO had more trabecular
bone volume, thickness and trabecular number than controls (p< 0.05).
We also observed that Act-cKO showed a much delayed hair re-growth
on the dorsal skin after hair removal compared with controls.
Conclusions: We have successfully generated an activin A conditional
knockout mouse and have validated the deletion at the mRNA and
protein level in a number of tissues including cartilage. We have dem-
onstrated functional loss of activin in bone by showing that these mice
have increased bone mass, a phenotype that is predicted by other in
vivo/vitro studies. The retarded hair re-growth phenotype in Act-cKO
mice was in agreement with the fact that constitutive activin A
knockout had no whiskers. We are currently awaiting the outcome of
the OA experiments to see whether disease is modulated by lack of
activin A.
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A SINGLE ADMINISTRATION OF DEXAMETHASONE MAY PROTECT
TIBIAL PLATEAU CARTILAGE IN A MECHANICALLY STABLE
SURGICAL MODEL OF POST TRAUMATIC OSTEOARTHRITIS
B.J. Heard, K.I. Barton, M. Chung, Y. Achari, N.G. Shrive, C.B. Frank,
D.A. Hart. Univ. of Calgary, Calgary, AB, Canada
Purpose: An acute inﬂammatory phase follows an injury to the knee
joint and initiates a cascade of biochemical events that can contribute to
degeneration of the cartilage. Cartilage degeneration after injury is
central in the development of posttraumatic osteoarthritis (PTOA) – a
debilitating disease that is increasingly affecting active younger indi-
viduals. It is currently believed that inﬂammation following intra-
articular bleeding from joint injuries could be a cause in the develop-
ment of PTOA. To study the effects of inﬂammation alone within the
joint, an injury model was developed in which tissue structures
responsible for joint function and stability were not directly impacted.
Preliminary evidence in this rabbit model of intra-articular bone injury,
intended to simulate posttraumatic hemarthrosis, has shown what
appears to be an acute inﬂammatory phase that resolves after surgery
and yet still results in the development of signiﬁcant PTOA. Therefore,
we hypothesize that if insult to the joint increases the expression level
of acute inﬂammatory mediators that expose the cartilage to injury
then an intervention that inhibits acute inﬂammation (dexamethasone)
will have positive outcomes on cartilage health within this rabbit bone
injury model. Dexamethasone (dex) is a glucocorticoid with potent
anti-inﬂammatory properties that has been widely adopted for clinical
use (e.g. in the treatment of rheumatoid arthritis, asthma, and various
cancers).
Methods: Skeletally mature adult female rabbits aged 52 weeks (n ¼
18) were used in this study. Six animals were not subjected to anyinterventions and served as un-operated controls. The remaining 12
were all subjected to a femoral notch drill surgery following the
guidelines of our institutional animal care facility. Of this group, six
rabbits were treated with one intra-articular injection of Dex (0.5 mg/
kg) at the time of surgery. As surgical controls, the remaining 6 animals
were subjected to drill surgery, but did not receive any dexamethasone
treatment. Animals were sacriﬁced at 9 weeks post surgery. Histological
assessment was completed by two blinded observers using a modiﬁed
Mankin protocol. qPCR was used to analyze the mRNA levels for select
anabolic and catabolic molecules, and values were normalized to 18S
mRNA. Kruskal-Wallis with Dunn’s multiple comparisons test were
used to investigate treatment group differences (signiﬁcance accepted
at p  0.05).
Results: Histological evaluations (Figure 1A) revealed that at 9 weeks
post surgery the cartilage on the tibial plateaus of the drill animals was
signiﬁcantly more damaged than that of the un-operated controls and
the animals that received the dex treatment after injury. There were no
signiﬁcant differences between the tibial plateau cartilage of the normal
and drill þ dex treatment groups, suggesting a positive role for dex-
amethasone. Furthermore, the mRNA analysis (Figure 1B) revealed that
even a single dose of dexamethasone at the time of surgery, was suf-
ﬁcient to attenuate the expression of degradative proteinase matrix
metalloproteinase 3 (MMP-3), proteoglycans such as versican and
biglycan as well as anabolic marker collagen type II (Col-II) in tibial
plateau cartilage.
Conclusions: Even in the absence of severe biomechanical changes, the
cartilage of the tibial plateau is subject to degeneration in this model.
This strongly suggests that initial biological changes are sufﬁcient to
drive many of the changes observed within the joint. The results of this
study suggest that Dexamethasone treatment given at the time of drill
surgery had a positive impact in reducing the degradation of the car-
tilage covering the tibial plateau. Interestingly, treatment with this
steroid attenuated the mRNA levels for both anabolic and catabolic
molecules.
Figure 1. Both panels represent data collected at 9 weeks post surgery.
(A.) Combined (medial and lateral tibial plateau) histological score. * ¼ p
 0.05, ** ¼ p  0.01. (B.) mRNA expression adjusted to percent of normal.
For each gene the normal expression was averaged, then the respective
values for Drill (D) and Drill þ Dex (D þ D) were divided by that value and
multiplied by 100.
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EFFECTIVE KNOCK DOWN OF MMP13 AND ADAMTS5 BY INTRA-
ARTICULAR INJECTION OF SMALL INTERFERENCE RNA (SIRNA) IN A
SURGICALLY INDUCED OSTEOARTHRITIS MODEL OF MICE
H. Hoshi, T. Sasho, R. Akagi, Y. Muramatsu, S. Mukoyama, Y. Akatsu,
T. Fukawa, J. Katsuragi, J. Endo, Y. Yamamoto. Graduate Sch. of Med.,
Chiba Univ., Chiba, Japan
Purpose: In the pathogenesis of osteoarthritis (OA), several proteases
including the MMP (matrix metalloproteinase) family and ADAMTS (a
disintegrin and metalloprotease with thrombospondin motifs) family
are thought to play a part in the early phase of cartilage degradation.
Among them, MMP13 and ADAMTS5 are presumed to be the major
players, and inhibition of those proteases has been demonstrated to
prevent cartilage degradation in animal osteoarthritic models. Small
interfering RNA (siRNA) silences speciﬁc genes by interfering with
mRNA translation, and acts to modulate or inhibit speciﬁc biological
pathways. siRNA has been proven to be beneﬁcial in knocking down
protease effects in vitro, but there are still unsolved problems before
applying this method in vivo, due to the molecular instability and
